Amerise Biosciences Limited (BOM:531681)

Amerise Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	0.24	0.22	0.21	0.14	0.13	0.19
Cash & Short-Term Investments	0.24	0.22	0.21	0.14	0.13	0.19
Cash Growth	49.06%	5.21%	55.15%	4.61%	-32.69%	-23.13%
Accounts Receivable	-	-	-	-	62.17	-
Receivables	-	-	-	-	62.17	-
Other Current Assets	0.05	0.05	0.02	-	-0	-
Total Current Assets	0.29	0.27	0.23	0.14	62.29	0.19
Long-Term Investments	37.7	23.81	22.65	45.66	46.91	30.41
Other Long-Term Assets	-	-	-	-	-0	-
Total Assets	83.93	84.63	53.9	56.47	119.88	56.28
Accounts Payable	-	-	-	-	62.66	4.8
Current Income Taxes Payable	-	0.02	-	-	-	-
Other Current Liabilities	30.64	30.82	0.16	0.37	0.01	0.57
Total Current Liabilities	30.64	30.84	0.16	0.37	62.67	5.38
Long-Term Debt	-	-	-	0.9	0.83	-
Other Long-Term Liabilities	-	-	-	-	-0	-
Total Liabilities	30.64	30.84	0.16	1.27	63.49	5.38
Common Stock	66.07	66.07	66.07	66.07	66.07	66.07
Retained Earnings	-	-13.09	-13.14	-11.68	-10.49	-15.98
Comprehensive Income & Other	-12.78	0.81	0.81	0.81	0.81	0.81
Shareholders' Equity	53.29	53.8	53.74	55.2	56.39	50.9
Total Liabilities & Equity	83.93	84.63	53.9	56.47	119.88	56.28
Total Debt	-	-	-	0.9	0.83	-
Net Cash (Debt)	0.24	0.22	0.21	-0.76	-0.7	0.19
Net Cash Growth	49.06%	5.21%	-	-	-	-23.13%
Net Cash Per Share	0.00	0.00	0.00	-0.01	-0.01	0.00
Filing Date Shares Outstanding	42.3	66.07	66.07	66.07	66.07	66.07
Total Common Shares Outstanding	42.3	66.07	66.07	66.07	66.07	66.07
Working Capital	-30.35	-30.57	0.07	-0.23	-0.37	-5.19
Book Value Per Share	1.26	0.81	0.81	0.84	0.85	0.77
Tangible Book Value	53.29	53.8	53.74	55.2	56.39	50.9
Tangible Book Value Per Share	1.26	0.81	0.81	0.84	0.85	0.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.